Muscular dystrophies are a group of heterogeneous diseases that are characterized by progressive muscle weakness, wasting and degeneration. These muscular deˆciencies are often caused by the loss of the protein dystrophin, a crucial element of the dystrophin-glycoprotein complex of muscleˆbers. Duchenne muscular dystrophy (DMD) is a fatal, Xlinked muscular disease that occurs in 1 out of every 3500 males. Therefore, feasible strategies for replacing or repairing the defective gene are required; however, to date, no eŠective therapeutic strategies for muscular dystrophies have been established. In this review, weˆrst introduce gene therapies mediated by adeno-associated viruses (AAVs) including a functional dystrophin cDNA or antisense oligonucleotide (AO)-induced exon-skipping therapies, which are designed to exclude the mutated or additional exon(s) in the defective gene and thereby correct the translational reading frame. Recently, we developed``Bubble liposomes'' (BLs), which are polyethylene glycol (PEG)-modiˆed liposomes entrapping echo-contrast gas that is known as ultrasound (US) imaging gas. BL application combined with US exposure can function as a novel gene delivery tool, and we demonstrate that the US-mediated eruption of BLs is a feasible and e‹cient technique to deliver plasmid DNA or AOs for the treatment of muscular dystrophies.

